Definigen raises £1.3m for stem cell advance – Business Weekly
|
Definigen raises £1.3m for stem cell advance
Business Weekly The company supplies human liver cells (hepatocytes) for preclinical drug development and disease modelling applications using human induced pluripotent stem cell technology. This is a trailblazing venture for the business and the university. The … Definigen attracts record Cambridge seed investmentGlobal University Venturing |
